Remove companies biomarin-pharmaceutical-inc
article thumbnail

Elliott Waives BioMarin Board Deal, Moots Del. Suit

Law 360

Elliott Investment Management LP has waived an agreement with BioMarin Pharmaceutical Inc. that gave the activist investor three new seats on the biopharmaceutical company's board, mooting a Delaware Chancery Court lawsuit that a BioMarin shareholder filed earlier this month.

Court 98
article thumbnail

BioMarin Hit With Del. Derivative Suit Over Missed Deadline

Law 360

A BioMarin Pharmaceutical Inc. stockholder on Friday launched a derivative suit in Delaware's Court of Chancery, seeking a company recovery for damages caused by alleged director failures to act promptly on threats that BioMarin would miss a key regulatory deadline for a valuable new hemophilia drug prospect.

Court 52